174 related articles for article (PubMed ID: 20558345)
1. The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization.
Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
Eur J Histochem; 2010 Jun; 54(2):e24. PubMed ID: 20558345
[TBL] [Abstract][Full Text] [Related]
2. HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization.
Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
Histol Histopathol; 2012 Jan; 27(1):113-21. PubMed ID: 22127603
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions.
Ruggeri RM; Sciacchitano S; Trimarchi F; Barresi G; Trovato M
Eur J Histochem; 2007; 51(3):193-8. PubMed ID: 17921114
[TBL] [Abstract][Full Text] [Related]
4. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.
Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S
Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120
[TBL] [Abstract][Full Text] [Related]
5. HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies.
Trovato M; Torre ML; Ragonese M; Simone A; Scarfì R; Barresi V; Giuffrè G; Benvenga S; Angileri FF; Tuccari G; Trimarchi F; Ruggeri RM; Cannavò S
Endocrine; 2013 Dec; 44(3):735-43. PubMed ID: 23576023
[TBL] [Abstract][Full Text] [Related]
6. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas.
Trovato M; Grosso M; Vitarelli E; Ruggeri RM; Alesci S; Trimarchi F; Barresi G; Benvenga S
Histol Histopathol; 2003 Apr; 18(2):393-9. PubMed ID: 12647789
[TBL] [Abstract][Full Text] [Related]
7. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells.
Matsumura A; Kubota T; Taiyoh H; Fujiwara H; Okamoto K; Ichikawa D; Shiozaki A; Komatsu S; Nakanishi M; Kuriu Y; Murayama Y; Ikoma H; Ochiai T; Kokuba Y; Nakamura T; Matsumoto K; Otsuji E
Int J Oncol; 2013 Feb; 42(2):535-42. PubMed ID: 23233163
[TBL] [Abstract][Full Text] [Related]
8. The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels among patients with euthyroid and hypothyroid goitrous and non-goitrous Hashimoto's thyroiditis versus healthy subjects.
Kilic MK; Yesilkaya Y; Tezcan K; Cinar N; Akin S; Karakaya J; Akata D; Usman A; Gurlek A
Endocr Res; 2016 May; 41(2):110-5. PubMed ID: 26726836
[TBL] [Abstract][Full Text] [Related]
9. Shear wave elastography in the diagnosis of thyroid nodules: feasibility in the case of coexistent chronic autoimmune Hashimoto's thyroiditis.
Magri F; Chytiris S; Capelli V; Alessi S; Nalon E; Rotondi M; Cassibba S; Calliada F; Chiovato L
Clin Endocrinol (Oxf); 2012 Jan; 76(1):137-41. PubMed ID: 21740455
[TBL] [Abstract][Full Text] [Related]
10. HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop.
Syed ZA; Yin W; Hughes K; Gill JN; Shi R; Clifford JL
BMC Cancer; 2011 May; 11():180. PubMed ID: 21595927
[TBL] [Abstract][Full Text] [Related]
11. Virtual touch tissue quantification (VTQ) in the diagnosis of thyroid nodules with coexistent chronic autoimmune Hashimoto's thyroiditis: a preliminary study.
Han R; Li F; Wang Y; Ying Z; Zhang Y
Eur J Radiol; 2015 Feb; 84(2):327-31. PubMed ID: 25481824
[TBL] [Abstract][Full Text] [Related]
12. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma.
Motoi T; Ishida T; Kuroda M; Horiuchi H; Oka T; Matsumoto K; Nakamura T; Machinami R
Pathol Int; 1998 Oct; 48(10):769-75. PubMed ID: 9788260
[TBL] [Abstract][Full Text] [Related]
14. Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay.
Dua R; Zhang J; Parry G; Penuel E
PLoS One; 2011 Jan; 6(1):e15932. PubMed ID: 21283737
[TBL] [Abstract][Full Text] [Related]
15. Delayed recanalization after MCAO ameliorates ischemic stroke by inhibiting apoptosis via HGF/c-Met/STAT3/Bcl-2 pathway in rats.
Tang H; Gamdzyk M; Huang L; Gao L; Lenahan C; Kang R; Tang J; Xia Y; Zhang JH
Exp Neurol; 2020 Aug; 330():113359. PubMed ID: 32428505
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
17. Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals.
Ruggeri RM; Sciacchitano S; Vitale A; Cardelli P; Galletti M; Vitarelli E; Barresi G; Benvenga S; Trimarchi F; Trovato M
J Endocrinol Invest; 2009 May; 32(5):465-9. PubMed ID: 19468262
[TBL] [Abstract][Full Text] [Related]
18. Possible association of CEA expression with oxyphilic change but not with C-cell hyperplasia in Hashimoto's thyroiditis.
Gakiopoulou H; Litsiou E; Valaris K; Balafoutas D; Patsouris E; Tseleni-Balafouta S
Endocr J; 2010; 57(8):693-9. PubMed ID: 20616436
[TBL] [Abstract][Full Text] [Related]
19. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
